Comparison of tPA-Assisted Rotational Thrombectomy and Lytic-Free Rheolytic Thrombectomy in Iliofemoral Deep Vein Thrombosis: 1-Year Outcomes
The European Research Journal · 2026-11-01 · 1324-1332
DOI: 10.18621/eurj.1334 ↗Abstract
Objective: To compare the efficacy and safety of lytic-free rheolytic mechanical thrombectomy vs tissue plasminogen activator (tPA)-assisted rotational thrombectomy combined with conventional balloon angioplasty for iliofemoral deep vein thrombosis (DVT) and to analyze periprocedural hematological stress and persistent limb asymmetry. Methods: Data from 88 patients treated endovascularly for unilateral iliofemoral DVT from 2020 to 2025 were retrospectively analyzed. Patients underwent either tPA-assisted rotational thrombectomy (group A, n = 58) or lytic-free rheolytic thrombectomy (group B, n = 30). Primary endpoints were safety (bleeding rates and hematocrit [HCT] decreases) and 1-year primary patency. Secondary endpoints included 1-year Villalta scores, bailout stenting rates and calf diameter asymmetry. Results: Bailout stenting rates following conventional balloon angioplasty were similar between group A and group B (19.0% vs 16.7%). Bleeding complications causing significant HCT decreases occurred in 15.5% (n = 9) of patients in group A, whereas no bleeding events occurred in group B (0%). Both devices induced mild, transient leukocyte increases and platelet decreases. At the 1-year follow-up, a total of 94.3% of patients with patent lumens achieved a Villalta score less than 5. However, significant calf diameter asymmetry persisted in 44.3% (n = 39) of the overall cohort. The 1-year primary patency rate was 87.9% for group A and 83.3% for group B (P = .53). Active malignancy significantly reduced 1-year primary patency to 68.4% compared with 91.3% in patients without malignancy. Conclusions: Lytic-free rheolytic thrombectomy significantly mitigates bleeding risks associated with tPA-assisted rotational thrombectomy while achieving equivalent 1-year patency outcomes. Furthermore, persistent calf asymmetry frequently remains despite symptomatic relief, indicating that limb diameter symmetry alone is an insufficient criterion for complete recovery or procedural success.
EUVIMED